In this paper, we present the results of our studies to investigate the expression level of the OCT4 splicing variant as a stem cell marker in samples of urothelial bladder cancer obtained from primary tumors and metastases to regional lymph nodes. This evidence concerns the gene POU5F1 and bladder transitional cell carcinoma.